Cargando…
Developing a morphomics framework to optimize implant site-specific design parameters for islet macroencapsulation devices
Delivering a clinically impactful cell number is a major design challenge for cell macroencapsulation devices for Type 1 diabetes. It is important to understand the transplant site anatomy to design a device that is practical and that can achieve a sufficient cell dose. We identify the posterior rec...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692035/ https://www.ncbi.nlm.nih.gov/pubmed/34932928 http://dx.doi.org/10.1098/rsif.2021.0673 |
_version_ | 1784618874791002112 |
---|---|
author | McDermott, Barry Robinson, Scott Holcombe, Sven Levey, Ruth E. Dockery, Peter Johnson, Paul Wang, Stewart Dolan, Eimear B. Duffy, Garry P. |
author_facet | McDermott, Barry Robinson, Scott Holcombe, Sven Levey, Ruth E. Dockery, Peter Johnson, Paul Wang, Stewart Dolan, Eimear B. Duffy, Garry P. |
author_sort | McDermott, Barry |
collection | PubMed |
description | Delivering a clinically impactful cell number is a major design challenge for cell macroencapsulation devices for Type 1 diabetes. It is important to understand the transplant site anatomy to design a device that is practical and that can achieve a sufficient cell dose. We identify the posterior rectus sheath plane as a potential implant site as it is easily accessible, can facilitate longitudinal monitoring of transplants, and can provide nutritive support for cell survival. We have investigated this space using morphomics across a representative patient cohort (642 participants) and have analysed the data in terms of gender, age and BMI. We used a shape optimization process to maximize the volume and identified that elliptical devices achieve a clinically impactful cell dose while meeting device manufacture and delivery requirements. This morphomics framework has the potential to significantly influence the design of future macroencapsulation devices to better suit the needs of patients. |
format | Online Article Text |
id | pubmed-8692035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Royal Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-86920352021-12-22 Developing a morphomics framework to optimize implant site-specific design parameters for islet macroencapsulation devices McDermott, Barry Robinson, Scott Holcombe, Sven Levey, Ruth E. Dockery, Peter Johnson, Paul Wang, Stewart Dolan, Eimear B. Duffy, Garry P. J R Soc Interface Life Sciences–Engineering interface Delivering a clinically impactful cell number is a major design challenge for cell macroencapsulation devices for Type 1 diabetes. It is important to understand the transplant site anatomy to design a device that is practical and that can achieve a sufficient cell dose. We identify the posterior rectus sheath plane as a potential implant site as it is easily accessible, can facilitate longitudinal monitoring of transplants, and can provide nutritive support for cell survival. We have investigated this space using morphomics across a representative patient cohort (642 participants) and have analysed the data in terms of gender, age and BMI. We used a shape optimization process to maximize the volume and identified that elliptical devices achieve a clinically impactful cell dose while meeting device manufacture and delivery requirements. This morphomics framework has the potential to significantly influence the design of future macroencapsulation devices to better suit the needs of patients. The Royal Society 2021-12-22 /pmc/articles/PMC8692035/ /pubmed/34932928 http://dx.doi.org/10.1098/rsif.2021.0673 Text en © 2021 The Authors. https://creativecommons.org/licenses/by/4.0/Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, provided the original author and source are credited. |
spellingShingle | Life Sciences–Engineering interface McDermott, Barry Robinson, Scott Holcombe, Sven Levey, Ruth E. Dockery, Peter Johnson, Paul Wang, Stewart Dolan, Eimear B. Duffy, Garry P. Developing a morphomics framework to optimize implant site-specific design parameters for islet macroencapsulation devices |
title | Developing a morphomics framework to optimize implant site-specific design parameters for islet macroencapsulation devices |
title_full | Developing a morphomics framework to optimize implant site-specific design parameters for islet macroencapsulation devices |
title_fullStr | Developing a morphomics framework to optimize implant site-specific design parameters for islet macroencapsulation devices |
title_full_unstemmed | Developing a morphomics framework to optimize implant site-specific design parameters for islet macroencapsulation devices |
title_short | Developing a morphomics framework to optimize implant site-specific design parameters for islet macroencapsulation devices |
title_sort | developing a morphomics framework to optimize implant site-specific design parameters for islet macroencapsulation devices |
topic | Life Sciences–Engineering interface |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692035/ https://www.ncbi.nlm.nih.gov/pubmed/34932928 http://dx.doi.org/10.1098/rsif.2021.0673 |
work_keys_str_mv | AT mcdermottbarry developingamorphomicsframeworktooptimizeimplantsitespecificdesignparametersforisletmacroencapsulationdevices AT robinsonscott developingamorphomicsframeworktooptimizeimplantsitespecificdesignparametersforisletmacroencapsulationdevices AT holcombesven developingamorphomicsframeworktooptimizeimplantsitespecificdesignparametersforisletmacroencapsulationdevices AT leveyruthe developingamorphomicsframeworktooptimizeimplantsitespecificdesignparametersforisletmacroencapsulationdevices AT dockerypeter developingamorphomicsframeworktooptimizeimplantsitespecificdesignparametersforisletmacroencapsulationdevices AT johnsonpaul developingamorphomicsframeworktooptimizeimplantsitespecificdesignparametersforisletmacroencapsulationdevices AT wangstewart developingamorphomicsframeworktooptimizeimplantsitespecificdesignparametersforisletmacroencapsulationdevices AT dolaneimearb developingamorphomicsframeworktooptimizeimplantsitespecificdesignparametersforisletmacroencapsulationdevices AT duffygarryp developingamorphomicsframeworktooptimizeimplantsitespecificdesignparametersforisletmacroencapsulationdevices |